ArticleJournal of cancer research and clinical oncology2020

Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome.

Lanlan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.